icon

DeepChek® Assay HIV-1 Full PR/RT/INT Drug Resistance

A broad HIV-1 drug resistance assay focused on amplification of the whole pol region, covering the reverse transcriptase, protease, and integrase coding areas used in resistance workflows.

HIV Genotyping & Drug Resistance

HIV-1 Full PR/RT/INT Drug Resistance

RUO

This assay is positioned for laboratories that need a combined HIV-1 PR/RT/INT sequencing target rather than separate region-by-region testing. It amplifies the relevant whole pol region and can support antiviral resistance assessment in HIV-infected samples.

Sequencing workflow HIV-1 DeepChek portfolio
DeepChek Assay HIV-1 Full PR/RT/INT Drug Resistance

Key Details

  • Targets the HIV-1 pol region with reverse transcriptase, protease, and integrase coverage.
  • Designed for drug-resistance workflows where a combined PR/RT/INT view is required.
  • Supports NGS report generation through DeepChek HIV software workflows.
  • Suitable when a laboratory needs a focused whole-pol option rather than whole-genome HIV-1 sequencing.

Workflow Snapshot

Target regionWhole pol region: PR / RT / INT
WorkflowSequencing-based HIV-1 genotyping
Report exampleNGS sequencing with DeepChek-HIV CE-IVD software
PositioningResearch-use drug resistance assay

Ordering Information

ProductReference
DeepChek Assay HIV-1 Full PR/RT/INT Drug Resistance (RUO)198A
DeepChek HIV Software (CE-IVD)S-12-023 (HL)

Implementation Note

Use this option when a combined PR, RT, and INT region analysis is preferred for HIV-1 drug resistance workflows.

Back To HIV Portfolio

Related HIV Assays